bullish
Classys (214150 KS): Record High Quarterly Performance in Q3; 2024 to Continue to Be Radiant
455 Views26 Nov 2023 01:15
SUMMARY
- Classys (214150 KS) reported solid performance in 3Q23, with revenue and operating profit growing 45% and 41%, YoY, respectively, mainly driven by export in devices and domestic sales of consumables.
- Despite being an offseason, Q3 2023 witnessed increase in both the number of countries selling the new product Ultraformer MPT and the monthly average domestic sales of Volnewmer.
- Continued improvement in equipment sale and increasing consumables contribution should drive growth in 2024. Entry into the U.S. and China will be the key for re-rating of the stock.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Classys (214150 KS): Beautiful Journey Continues; Record High Revenue and Operating Profit in 1Q2409 May 2024
- Classys: One of Korea's Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends08 Mar 2024
- Classys (214150 KS): 2023 Sales Beat Guidance to Reach Record High; Stellar Performance to Continue01 Mar 2024
- Classys (214150 KS): Beautiful Growth Story Continues; No Sign of Slowing Down11 Sep 2023
- Classys (214150 KS): Strong 1Q23 Result Lifted by Overseas Performance and Consumables Sales26 May 2023
- Classys (214150 KS): Record-High Sales and Profit in 2022; Geography Expansion to Accelerate Growth17 Feb 2023
x